Literature DB >> 21454879

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum.

Dimitri A Breems, Bob Löwenberg.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21454879      PMCID： PMC3069222          DOI： 10.3324/haematol.2011.043208

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Acute myeloid leukemia.

Authors:  B Löwenberg; J R Downing; A Burnett
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

2.  Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities.

Authors:  E H Estey; S Pierce; M J Keating
Journal:  Haematologica       Date:  2000-03       Impact factor: 9.941

3.  Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Authors:  Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; Simon M G Daenen; Marinus van Marwijk Kooy; Pierre Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

4.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

Review 5.  Therapeutic advances in acute myeloid leukemia.

Authors:  Alan Burnett; Meir Wetzler; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

6.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.

Authors:  Bruno C Medeiros; Megan Othus; Min Fang; Diane Roulston; Frederick R Appelbaum
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

7.  High-dose daunorubicin in older patients with acute myeloid leukemia.

Authors:  Bob Löwenberg; Gert J Ossenkoppele; Wim van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Johan Maertens; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Marinus van Marwijk Kooy; Leo F Verdonck; Joachim Beck; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gregor Verhoef
Journal:  N Engl J Med       Date:  2009-09-24       Impact factor: 91.245

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.

Authors:  Dimitri A Breems; Wim L J Van Putten; Georgine E De Greef; Shama L Van Zelderen-Bhola; Klasien B J Gerssen-Schoorl; Clemens H M Mellink; Aggie Nieuwint; Martine Jotterand; Anne Hagemeijer; H Berna Beverloo; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2008-08-11       Impact factor: 44.544

Review 10.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Authors:  John Koreth; Richard Schlenk; Kenneth J Kopecky; Sumihisa Honda; Jorge Sierra; Benjamin J Djulbegovic; Martha Wadleigh; Daniel J DeAngelo; Richard M Stone; Hisashi Sakamaki; Frederick R Appelbaum; Hartmut Döhner; Joseph H Antin; Robert J Soiffer; Corey Cutler
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272
View more
  8 in total

1.  Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.

Authors:  Heesun J Rogers; James W Vardiman; John Anastasi; Gordana Raca; Natasha M Savage; Athena M Cherry; Daniel Arber; Erika Moore; Jennifer J D Morrissette; Adam Bagg; Yen-Chun Liu; Susan Mathew; Attilio Orazi; Pei Lin; Sa A Wang; Carlos E Bueso-Ramos; Kathryn Foucar; Robert P Hasserjian; Ramon V Tiu; Matthew Karafa; Eric D Hsi
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941

2.  Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.

Authors:  Norman J Lacayo; Todd A Alonzo; Urte Gayko; David B Rosen; Matt Westfall; Norman Purvis; Santosh Putta; Brent Louie; James Hackett; Aileen Cleary Cohen; Alessandra Cesano; Robert Gerbing; Yaddanapudi Ravindranath; Gary V Dahl; Alan Gamis; Soheil Meshinchi
Journal:  Br J Haematol       Date:  2013-05-20       Impact factor: 6.998

3.  Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia.

Authors:  S S Kenderian; A Al-Kali; N Gangat; L Letendre; W J Hogan; M R Litzow; M M Patnaik
Journal:  Blood Cancer J       Date:  2013-07-05       Impact factor: 11.037

4.  Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Authors:  Lisa Pleyer; Sonja Burgstaller; Michael Girschikofsky; Werner Linkesch; Reinhard Stauder; Michael Pfeilstocker; Martin Schreder; Christoph Tinchon; Thamer Sliwa; Alois Lang; Wolfgang R Sperr; Peter Krippl; Dietmar Geissler; Daniela Voskova; Konstantin Schlick; Josef Thaler; Sigrid Machherndl-Spandl; Georg Theiler; Otto Eckmüllner; Richard Greil
Journal:  Ann Hematol       Date:  2014-06-21       Impact factor: 3.673

5.  Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Authors:  Aleksandr Lazaryan; Michelle Dolan; Mei-Jie Zhang; Hai-Lin Wang; Mohamed A Kharfan-Dabaja; David I Marks; Nelli Bejanyan; Edward Copelan; Navneet S Majhail; Edmund K Waller; Nelson Chao; Tim Prestidge; Taiga Nishihori; Partow Kebriaei; Yoshihiro Inamoto; Betty Hamilton; Shahrukh K Hashmi; Rammurti T Kamble; Ulrike Bacher; Gerhard C Hildebrandt; Patrick J Stiff; Joseph McGuirk; Ibrahim Aldoss; Amer M Beitinjaneh; Lori Muffly; Ravi Vij; Richard F Olsson; Michael Byrne; Kirk R Schultz; Mahmoud Aljurf; Matthew Seftel; Mary Lynn Savoie; Bipin N Savani; Leo F Verdonck; Mitchell S Cairo; Nasheed Hossain; Vijaya Raj Bhatt; Haydar A Frangoul; Hisham Abdel-Azim; Monzr Al Malki; Reinhold Munker; David Rizzieri; Nandita Khera; Ryotaro Nakamura; Olle Ringdén; Marjolein van der Poel; Hemant S Murthy; Hongtao Liu; Shahram Mori; Satiro De Oliveira; Javier Bolaños-Meade; Mahmoud Elsawy; Pere Barba; Sunita Nathan; Biju George; Attaphol Pawarode; Michael Grunwald; Vaibhav Agrawal; Youjin Wang; Amer Assal; Paul Castillo Caro; Yachiyo Kuwatsuka; Sachiko Seo; Celalettin Ustun; Ioannis Politikos; Hillard M Lazarus; Wael Saber; Brenda M Sandmaier; Marcos De Lima; Mark Litzow; Veronika Bachanova; Daniel Weisdorf
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

6.  Unified classification and risk-stratification in Acute Myeloid Leukemia.

Authors:  Nigel H Russell; Sean M Devlin; Brian J P Huntly; Elli Papaemmanuil; Yanis Tazi; Juan E Arango-Ossa; Yangyu Zhou; Elsa Bernard; Ian Thomas; Amanda Gilkes; Sylvie Freeman; Yoann Pradat; Sean J Johnson; Robert Hills; Richard Dillon; Max F Levine; Daniel Leongamornlert; Adam Butler; Arnold Ganser; Lars Bullinger; Konstanze Döhner; Oliver Ottmann; Richard Adams; Hartmut Döhner; Peter J Campbell; Alan K Burnett; Michael Dennis
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

7.  Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine.

Authors:  T Cluzeau; C Moreilhon; N Mounier; J-M Karsenti; L Gastaud; G Garnier; D Re; N Montagne; J Gutnecht; P Auberger; J G Fuzibet; J-P Cassuto; S Raynaud
Journal:  Blood Cancer J       Date:  2013-11-01       Impact factor: 11.037

8.  Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?

Authors:  Shannon R McCurdy; Selina M Luger
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.